J&J Tells Patent Board Cataract Removal Method Would Be Obvious
ALEXANDRIA, Va. — In a June 11 petition for inter partes review (IPR), Johnson & Johnson Surgical Vision Inc. (J&J) asserts that 11 claims of a patented “Phodisruptive Laser Treatment of...To view the full article, register now.
Already a subscriber? Click here to view full article